FDA Import Refusal AEK-3014810-8/21/1 — Glaxosmithkline
The FDA refused shipment AEK-3014810-8/21/1 from Glaxosmithkline (United Kingdom) on Apr 5, 2023. The refused product falls under Drugs and Biologics — BUPROPION HCL (ANTI-DEPRESSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 5, 2023
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61NCF05 BUPROPION HCL (ANTI-DEPRESSANT)
- Charges
- 75